Other Haematological Agents
Other Haematological Agents Companies (6)
Other Haematological Agents News
-
News Pfizer boosts rare disease pipeline with $5.4B acquisition of Global Blood Therapeutics
The $5.4 billion deal marks Pfizer's fourth acquisition in the last nine months
Other Haematological Agents Products (8)
-
Product Hemax 1.000/2.000/3.000/4.000/10.000/20.000/40.000 IU
Hemax is a synthetic form of human erythropoietin, used to treat anemia. Biosidus recombinant human erythropoietin, our flagship product, is obtained by mass cell culture of genetically modified mammalian cells. Our epoetin is available in a convenient thermostable formulation as freeze dried powder for in...
-
Product Etamsylate Injection
Etamsylate Injection is a high-quality sterile hemostatic agent manufactured by Montage Laboratories Pvt. Ltd. Each ampoule contains Etamsylate, which helps reduce capillary bleeding by improving platelet adhesion and capillary wall stability without affecting normal coagulation mechanisms.
It...
-
Product Emacrit
Thanks to a specific formula, Emacrit® improves iron level and contributes to the formation of red blood cells and to the reduction of tiredness and fatigue. Formulated with Vitamins C, B6, B12, folic acid and an innovative and patented iron source (microencapsulated and micronized iron saccharate) to guar...
-
Product Etamsylate for Injection
Advantages:1.China-exclusive and the sole export product;
2.Dual-target hemostasis, rapid-acting, long-lasting and safe profile;
3.First choice for hemostasis recommended in multiple guidelines.
Indications:
For the prevention and treatment of bleeding before and after various surgeries...
-
Product GPO-L-ONE
Deferiprone Tablet 500 mg
Iron Chelating Agent
For Treatment of iron overload in thalassemia patients
Oral Iron Chelator for Good Compliance
High Affinity for iron Binding
Effective Removal of Excess Iron from the Body
Provides Significant Ca...
-
Product Recombinant Human Coagulation Factor VIII for Injection
Rongsheng™ Recombinant Human Coagulation Factor VIII for Injection is a protein drug with the same coagulation activity as natural human coagulation factor VIII, which is prepared by DNA recombination technology, Chinese hamster ovary (CHO) cell culture, protein purification and multi-step virus ...
Upcoming Events
-
CPHI & PMEC China 2026
Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026 -
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026 -
CPHI Korea 2026
COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026
